Case-Control Study to Estimate the Association Between Tdap Vaccination During Pregnancy and Reduced Risk of Pertussis in Newborn Infants in Peru, 2019-2021.

Eduardo Juscamayta-LópezFaviola ValdiviaMaría Pía SotoHelen HornaMónica Pajuelo

Published in: Open forum infectious diseases (2023)

Peruvian infants <2 months old whose mothers received the Tdap vaccine in the third trimester of pregnancy had a significantly lower risk of pertussis. The Tdap vaccination is thus an effective intervention to reduce the burden of pertussis in at-risk populations.

Keyphrases

preterm birth
randomized controlled trial
pregnancy outcomes